Connection

Jim Oates to Lupus Erythematosus, Systemic

Back to Details
This is a "connection" page, showing publications Jim Oates has written about Lupus Erythematosus, Systemic.
Jim Oates
Connection Strength
6.406
Lupus Erythematosus, Systemic
  1. Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value. Front Immunol. 2021; 12:694318.
    View in: PubMed
    Score: 0.471
  2. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity. PLoS One. 2019; 14(11):e0224496.
    View in: PubMed
    Score: 0.419
  3. IFN-a Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus. J Immunol. 2017 09 15; 199(6):1979-1988.
    View in: PubMed
    Score: 0.358
  4. Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring. Am J Med Sci. 2017 06; 353(6):580-592.
    View in: PubMed
    Score: 0.346
  5. Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN): study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans. BMC Health Serv Res. 2016 08 02; 16(a):339.
    View in: PubMed
    Score: 0.334
  6. A Pilot Study to Determine if Vitamin D Repletion Improves Endothelial Function in Lupus Patients. Am J Med Sci. 2015 Oct; 350(4):302-7.
    View in: PubMed
    Score: 0.315
  7. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci. 2012 Oct; 344(4):268-73.
    View in: PubMed
    Score: 0.256
  8. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity. 2010 Feb; 43(1):56-63.
    View in: PubMed
    Score: 0.213
  9. The place of William Osler in the description of systemic lupus erythematosus. Am J Med Sci. 2009 Nov; 338(5):409-12.
    View in: PubMed
    Score: 0.209
  10. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum. 2008 Jan; 58(1):263-72.
    View in: PubMed
    Score: 0.184
  11. Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Arthritis Rheum. 2007 Nov; 56(11):3738-47.
    View in: PubMed
    Score: 0.182
  12. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol. 2006 Dec; 121(3):243-50.
    View in: PubMed
    Score: 0.167
  13. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. J Investig Med. 2004 Jan; 52(1):62-71.
    View in: PubMed
    Score: 0.139
  14. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans. J Rheumatol. 2003 Jan; 30(1):60-7.
    View in: PubMed
    Score: 0.130
  15. Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus. Ann Rheum Dis. 2022 Dec; 81(12):1712-1721.
    View in: PubMed
    Score: 0.127
  16. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun. 2022 07; 131:102860.
    View in: PubMed
    Score: 0.126
  17. Developing and Validating Methods to Assemble Systemic Lupus Erythematosus Births in the Electronic Health Record. Arthritis Care Res (Hoboken). 2022 05; 74(5):849-857.
    View in: PubMed
    Score: 0.123
  18. A Distinct Plasma Microbiome But Not Gut Microbiome in Patients With Systemic Lupus Erythematosus Compared to Healthy Individuals. J Rheumatol. 2022 06; 49(6):592-597.
    View in: PubMed
    Score: 0.122
  19. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 03; 74(3):496-507.
    View in: PubMed
    Score: 0.122
  20. Polymyalgia Rheumatica or Late Onset Lupus? A Case Report. J Investig Med High Impact Case Rep. 2022 Jan-Dec; 10:23247096221089493.
    View in: PubMed
    Score: 0.121
  21. Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 01; 74(1):112-123.
    View in: PubMed
    Score: 0.121
  22. Prediction models of treatment response in lupus nephritis. Kidney Int. 2022 02; 101(2):379-389.
    View in: PubMed
    Score: 0.121
  23. The Care-coordination Approach to Learning Lupus Self-Management: a patient navigator intervention for systemic lupus inpatients. Lupus Sci Med. 2021 05; 8(1).
    View in: PubMed
    Score: 0.116
  24. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999 Nov-Dec; 111(6):611-21.
    View in: PubMed
    Score: 0.104
  25. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients. Arthritis Rheumatol. 2019 11; 71(11):1858-1868.
    View in: PubMed
    Score: 0.104
  26. Peer approaches to self-management (PALS): comparing a peer mentoring approach for disease self-management in African American women with lupus with a social support control: study protocol for a randomized controlled trial. Trials. 2019 Aug 23; 20(1):529.
    View in: PubMed
    Score: 0.103
  27. Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study. Lupus. 2019 Jul; 28(8):937-944.
    View in: PubMed
    Score: 0.102
  28. My life with lupus: contextual responses of African-American women with systemic lupus participating in a peer mentoring intervention to improve disease self-management. BMJ Open. 2018 11 08; 8(11):e022701.
    View in: PubMed
    Score: 0.098
  29. The SLE-key test serological signature: new insights into the course of lupus. Rheumatology (Oxford). 2018 09 01; 57(9):1632-1640.
    View in: PubMed
    Score: 0.096
  30. Peer-to-Peer Mentoring for African American Women With Lupus: A Feasibility Pilot. Arthritis Care Res (Hoboken). 2018 06; 70(6):908-917.
    View in: PubMed
    Score: 0.094
  31. Word2Vec inversion and traditional text classifiers for phenotyping lupus. BMC Med Inform Decis Mak. 2017 Aug 22; 17(1):126.
    View in: PubMed
    Score: 0.090
  32. Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus. Am J Med Sci. 2018 03; 355(3):293-298.
    View in: PubMed
    Score: 0.089
  33. Cytokine balance and behavioral intervention; findings from the Peer Approaches to Lupus Self-Management (PALS) project. Hum Immunol. 2017 Sep; 78(9):574-581.
    View in: PubMed
    Score: 0.089
  34. "We Would Still Find Things to Talk About": Assessment of Mentor Perspectives in a Systemic Lupus Erythematosus Intervention to Improve Disease Self-Management, Empowering SLE Patients. J Natl Med Assoc. 2018 Apr; 110(2):182-189.
    View in: PubMed
    Score: 0.088
  35. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J Leukoc Biol. 2016 Feb; 99(2):265-78.
    View in: PubMed
    Score: 0.080
  36. SLE-key(?) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(?). J Immunol Methods. 2016 Feb; 429:1-6.
    View in: PubMed
    Score: 0.080
  37. A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression. Arthritis Rheumatol. 2014 Dec; 66(12):3436-44.
    View in: PubMed
    Score: 0.074
  38. Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. J Rheumatol. 2013 Jun; 40(6):842-9.
    View in: PubMed
    Score: 0.067
  39. Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma sphingolipid levels in lupus. Cell Immunol. 2012 Mar-Apr; 276(1-2):42-51.
    View in: PubMed
    Score: 0.062
  40. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010 Jan; 62(1):222-33.
    View in: PubMed
    Score: 0.053
  41. Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. J Rheumatol. 2007 Oct; 34(10):2028-34.
    View in: PubMed
    Score: 0.045
  42. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA. J Rheumatol. 2007 Apr; 34(4):734-9.
    View in: PubMed
    Score: 0.044
  43. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol. 1999 Feb; 26(2):318-24.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.